FOXP3 and cancer: Notably, the potential role of USP44 as a regulator of the anti‐tumor immune response was not explored in any of these studies, and, indeed, the ability of this and other DUBs to control FOXP3 expression and Treg function in cancer has yet to be explored in detail.